報價延遲最少15分鐘:2025/06/02 20:04 EDT
|
|
|
|
|
||||||||||||
|
|
|
|
|
1.81 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-0.74/0.75
|
|
企業價值
248.58M
|
| 資產負債 |
|
每股賬面淨值
0.22
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
0
|
|
每股收益
--
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/06/02 20:04 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| "HeartBeam Inc is a medical technology company primarily focusing on developing and commercializing higher resolution ambulatory Electrocardiogram (""ECG"") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography (""VECG"") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration (""FDA"") clearance for its initial telehealth products." |